Dr. Charles Marmar, MD
Claim this profileNew York University School of Medicine
Studies Post-Traumatic Stress Disorder
Studies Alcoholism
5 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Charles Marmar, MD is currently running
Cannabidiol
for PTSD
This will be a randomized placebo controlled study to test the efficacy of cannabidiol (CBD) as a treatment for symptoms of post-traumatic stress disorder (PTSD). Subjects, 120 in total, will be males and females with PTSD, half of which will have comorbid mild traumatic brain injury (TBI). There will be three study arms, each with 40 subjects: 1) Oral CBD 400 mg daily; 2) Oral CBD 800 mg daily, and 3) Placebo daily. Treatment duration will be 8 weeks. The primary outcome will be change in PTSD symptoms as measured by change in the Clinician-Administered PTSD Scale (CAPS-5) total score.
Recruiting0 awards Phase 24 criteria
Topiramate
for AUD and PTSD
This is a double-blind, 2-group randomized controlled trial evaluating the effects of topiramate versus placebo in patients with comorbid PTSD and moderate-to-severe AUD. This trial will provide one of the first rigorous tests of whether the effects of topiramate in AUD generalize to patients with co-occurring PTSD, and one of the first rigorous tests of whether topiramate has beneficial effects on PTSD symptoms in this population. It will be the first study to test whether the rs2832407 genotype predicts clinical response to topiramate for AUD and PTSD in patients with both disorders. Further, it will contribute to the understanding of topiramate's mechanisms of action in the co-morbid AUD/PTSD population, and to the discovery of predictors of treatment response.
Recruiting0 awards Phase 29 criteria
More about Charles Marmar, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Charles Marmar, MD has experience with
- Cannabidiol
- Placebo
- Topiramate
- Placebos
- PRISM
- Prism System
Breakdown of trials Charles Marmar, MD has run
Post-Traumatic Stress Disorder
Traumatic Brain Injury
Brain Injury
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles Marmar, MD specialize in?
Charles Marmar, MD focuses on Post-Traumatic Stress Disorder and Alcoholism. In particular, much of their work with Post-Traumatic Stress Disorder has involved treating patients, or patients who are undergoing treatment.
Is Charles Marmar, MD currently recruiting for clinical trials?
Yes, Charles Marmar, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Charles Marmar, MD has studied deeply?
Yes, Charles Marmar, MD has studied treatments such as Cannabidiol, Placebo, Topiramate.
What is the best way to schedule an appointment with Charles Marmar, MD?
Apply for one of the trials that Charles Marmar, MD is conducting.
What is the office address of Charles Marmar, MD?
The office of Charles Marmar, MD is located at: New York University School of Medicine, New York, New York 10016 United States. This is the address for their practice at the New York University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.